1.Kirmayer LJ, Brass GM & Tait CL (2000) The mental health of Aboriginal peoples: transformations of identity and community. Can J Psychiatry 45, 607–616.
2.McGrath-Hanna NK, Greene DM, Tavernier RJ & Bult-Ito A (2003) Diet and mental health in the Arctic: is diet an important risk factor for mental health in circumpolar peoples? A review. Int J Circumpolar Health 62, 228–241.
3.Boothroyd LJ, Kirmayer LJ, Spreng S, Malus M & Hodgins S (2000) Completed suicides among the Inuit of northern Quebec, 1982–1996: a case–control study. CMAJ 165, 749–755.
4.Waldram JB, Herring DA & Young TK (2006) Aboriginal Health in Canada: Historical, Cultural, and Epidemiological Perspectives, 2nd ed. Toronto: University of Toronto Press.
5.Kirmayer LJ, Macdonald ME & GM Brass (2000) The Mental Health of Indigenous Peoples. Report no. 10. Montreal: Culture & Mental Health Research Unit, Institute of Community & Family Psychiatry, Sir Mortimer B. Davis–Jewish General Hospital.
6.Chandler MJ & Lalonde C (1998) Cultural continuity as a hedge against suicide in Canada’s First Nations. Transcult Psychiatry 35, 191–219.
7.Haggarty J, Cernovsky Z, Kermeen P & Merskey H (2000) Psychiatric disorders in an Arctic community. Can J Psychiatry 45, 357–362.
8.Lavallée C, Robinson E & Laverdure J (1991) Description of customers and services of mental health among the Cree people (North Quebec). Sante Cult 8, 265–284.
9.Santé-Québec , Daveluy C & Bertrand L (editors) (1998) A Dietary Profile of the Cree: Report of the Santé Québec Health Survey of the James Bay Cree, 1991: Food and Nutrient Intake. Montréal: Ministère de la santé et des services sociaux, Government of Quebec.
10.Santé Québec , Daveluy C, Lavallée C, Clarkson M & Robinson E (editors) (1994) A Health Profile of the Cree: Report of the Santé Québec Health Survey of the James Bay Cree 1991. Montréal: Ministère de la santé et des services sociaux, Government of Quebec.
11.Prince RH (1993) Psychiatry among the James Bay Cree: a focus on pathological grief reactions. Transcult Psychiatry Res Rev 30, 3–50.
12.Dewailly E, Blanchet C, Gingras S, Lemieux S & Holub BJ (2002) Cardiovascular disease risk factors and n-3 fatty acid status in the adult population of James Bay Cree. Am J Clin Nutr 76, 85–92.
13.Hibbeln JR & Salem N Jr (1995) Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 62, 1–9.
14.Parker G, Gibson NA, Brotchie H, Heruc G, Rees AM & Hadzi-Pavlovic D (2006) Omega-3 fatty acids and mood disorders. Am J Psychiatry 163, 969–978.
15.Sontrop J & Campbell MK (2006) Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. Prev Med 42, 4–13.
16.Plourde M & Cunnane S (2007) Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 32, 619–634.
17.Kobayashi M, Sasaki S, Kawabata T, Hasegawa K & Tsugane S (2003) Validity of a self-administered food frequency questionnaire used in the 5-year follow-up survey of the JPHC Study Cohort I to assess fatty acid intake: comparison with dietary records and serum phospholipid level. J Epidemiol 13, 1 Suppl., S64–S81.
18.Kuriki K, Nagaya T, Tokudome Y et al. (2003) Plasma concentrations of (n-3) highly unsaturated fatty acids are good biomarkers of relative dietary fatty acid intakes: a cross-sectional study. J Nutr 133, 3643–3650.
19.Hjartaker A, Lund E & Bjerve KS (1997) Serum phospholipid fatty acid composition and habitual intake of marine foods registered by a semi-quantitative food frequency questionnaire. Eur J Clin Nutr 51, 736–742.
20.Yehuda S, Rabinovitz S & Mostofsky DI (1999) Essential fatty acids are mediators of brain biochemistry and cognitive functions. J Neurosci Res 56, 565–570.
21.Martinez M (1992) Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 120, s129–s138.
22.McNamara RK & Carlson SE (2006) Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids 75, 329–349.
23.Delion S, Chalon S, Guilloteau D, Besnard JC & Durand G (1996) α-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J Neurochem 66, 1582–1591.
24.Delion S, Chalon S, Guilloteau D, Lejeune B, Besnard JC & Durand G (1997) Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet. J Lipid Res 38, 680–689.
25.Delion S, Chalon S, Hérault J, Guilloteau D, Besnard J-C & Durand G (1994) Chronic dietary α-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J Nutr 124, 2466–2476.
26.de la Presa Owens S & Innis SM (1999) Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and α-linolenic acid deficient diet in formula-fed piglets. J Nutr 129, 2088–2093.
27.Kodas E, Galineau L, Bodard S, Vancassel S, Guilloteau D, Besnard JC & Chalon S (2004) Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat. J Neurochem 89, 695–702.
28.Hibbeln JR, Umhau JC, Linnoila M, George DT, Ragan PW, Shoaf SE, Vaughan MR, Rawlings R & Salem N Jr (1998) A replication study of violent and nonviolent subjects: cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids. Biol Psychiatry 44, 243–249.
29.Hibbeln JR, Linnoila M, Umhau JC, Rawlings R, George DT & Salem N Jr (1998) Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics. Biol Psychiatry 44, 235–242.
30.Serhan CN (2005) Novel omega-3 derived local mediators in anti-inflammation and resolution. Pharmacol Ther 105, 7–21.
31.Farooqui AA, Horrocks LA & Farooqui T (2007) Modulation of inflammation in brain: a matter of fat. J Neurochem 101, 577–599.
32.Haag M (2003) Essential fatty acids and the brain. Can J Psychiatry 48, 195–203.
33.Stahl LA, Begg DP, Weisinger RS & Sinclair AJ (2008) The role of omega-3 fatty acids in mood disorders. Curr Opin Invest Drugs 9, 57–64.
34.Kirmayer LJ, Boothroyd LJ, Tanner A, Adelson N & Robinson E (2000) Psychological distress among the Cree of James Bay. Transcult Psychiatry 37, 35–56.
35.Préville M, Boyer R & Potvin L (1992) La détresse psychologique: détermination de la fiabilité et de la validité de la mesure utilisée dans l’enquête Santé Québec, enquête Santé Québec 1987. Les cahiers de recherche no. 7. Montréal: Ministère de la santé et des services sociaux, Government of Quebec.
36.Preville M, Potvin L & Boyer R (1995) The structure of psychological distress. Psychol Rep 77, 275–293.
37.Ilfeld FW Jr (1978) Psychologic status of community residents along major demographic dimensions. Arch Gen Psychiatry 35, 716–724.
38.Ilfeld FW (1976) Further validation of a psychiatric symptom index in a normal population. Psychol Rep 39, 1215–1228.
39.Martin F, Sabourin S & Gendreau P (1989) Les dimensions de la detresse psychologique: analyse factorielle confirmatoire de type hierarchique. Int J Psychol 24, 571–584.
40.Boyer R, Preville M, Legare G & Valois P (1993) Psychological distress in a noninstitutionalized population of Quebec: normative results of the Quebec health survey. Can J Psychiatry 38, 339–343.
41.Stark KD & Holub BJ (2004) Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy. Am J Clin Nutr 79, 765–773.
42.Babyak MA (2004) What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 66, 411–421.
43.Peduzzi P, Concato J, Kemper E, Holford TR & Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49, 1373–1379.
44.Steyerberg EW, Eijkemans MJ, Harrell FE Jr & Habbema JD (2001) Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets. Med Decis Making 21, 45–56.
45.Timonen M, Horrobin D, Jokelainen J, Laitinen J, Herva A & Rasanen P (2004) Fish consumption and depression: the Northern Finland 1966 birth cohort study. J Affect Disord 82, 447–452.
46.Tanskanen A, Hibbeln JR, Tuomilehto J, Uutela A, Haukkala A, Viinamaki H, Lehtonen J & Vartiainen E (2001) Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv 52, 529–531.
47.Kamphuis MH, Geerlings MI, Tijhuis MA, Kalmijn S, Grobbee DE & Kromhout D (2006) Depression and cardiovascular mortality: a role for n-3 fatty acids? Am J Clin Nutr 84, 1513–1517.
48.Feart C, Peuchant E, Letenneur L, Samieri C, Montagnier D, Fourrier-Reglat A & Barberger-Gateau P (2008) Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three-City Study. Am J Clin Nutr 87, 1156–1162.
49.Lucas M, Dewailly E, Blanchet B, Gingras S & Holub BJ (2009) Plasma omega-3 and psychological distress among Nunavik Inuit (Canada). Psychiatry Res (In the Press).
50.Raeder MB, Steen VM, Vollset SE & Bjelland I (2007) Associations between cod liver oil use and symptoms of depression: the Hordaland Health Study. J Affect Disord 101, 245–249.
51.Suzuki S, Akechi T, Kobayashi M, Taniguchi K, Goto K, Sasaki S, Tsugane S, Nishiwaki Y, Miyaoka H & Uchitomi Y (2004) Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer. Br J Cancer 90, 787–793.
52.Silvers KM & Scott KM (2002) Fish consumption and self-reported physical and mental health status. Public Health Nutr 5, 427–431.
53.Kidd PM (2007) Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural–functional synergies with cell membrane phospholipids. Altern Med Rev 12, 207–227.
54.Arterburn LM, Hall EB & Oken H (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83, 6 Suppl., 1467S–1476S.
55.Brown AJ, Pang E & Roberts DCK (1991) Erythrocyte eicosapentaenoic acid versus docosahexaenoic acid as a marker for fish and fish oil consumption. Prostaglandins Leukot Essent Fatty Acids 44, 103–106.
56.Brown AJ, Pang E & Roberts DC (1991) Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n-3 polyunsaturated fatty acids: study design implications. Am J Clin Nutr 54, 668–673.
57.Mina K, Fritschi L & Knuiman M (2007) A valid semiquantitative food frequency questionnaire to measure fish consumption. Eur J Clin Nutr 61, 1023–1031.
58.Woods RK, Stoney RM, Ireland PD, Bailey MJ, Raven JM, Thien FC, Walters EH & Abramson MJ (2002) A valid food frequency questionnaire for measuring dietary fish intake. Asia Pac J Clin Nutr 11, 56–61.
59.Harris WS & Von Schacky C (2004) The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 39, 212–220.
60.Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D & Lonnqvist J (2004) Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry 161, 567–569.
61.Sanchez-Villegas A, Henriquez P, Figueiras A, Ortuno F, Lahortiga F & Martinez-Gonzalez MA (2007) Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study. Eur J Nutr 46, 337–346.
62.Lowe B, Spitzer RL, Grafe K, Kroenke K, Quenter A, Zipfel S, Buchholz C, Witte S & Herzog W (2004) Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord 78, 131–140.
63.Bijl RV, de Graaf R, Hiripi E et al. (2003) The prevalence of treated and untreated mental disorders in five countries. Health Aff (Millwood) 22, 122–133.
64.Lin PY & Su KP (2007) A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 68, 1056–1061.
65.Appleton KM, Hayward RC, Gunnell D, Peters TJ, Rogers PJ, Kessler D & Ness AR (2006) Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr 84, 1308–1316.
66.Green P, Hermesh H, Monselise A, Marom S, Presburger G & Weizman A (2006) Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder. Eur Neuropsychopharmacol 16, 107–113.
67.Buydens-Branchey L & Branchey M (2006) n-3 Polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers. J Clin Psychopharmacol 26, 661–665.
68.Fux M, Benjamin J & Nemets B (2004) A placebo-controlled cross-over trial of adjunctive EPA in OCD. J Psychiatr Res 38, 323–325.
69.Hallahan B & Garland MR (2004) Essential fatty acids and their role in the treatment of impulsivity disorders. Prostaglandins Leukot Essent Fatty Acids 71, 211–216.
70.Hallahan B, Hibbeln JR, Davis JM & Garland MR (2007) Omega-3 fatty acid supplementation in patients with recurrent self-harm. Single-centre double-blind randomised controlled trial. Br J Psychiatry 190, 118–122.
71.Kobayashi M, Sasaki S, Kawabata T, Hasegawa K, Akabane M & Tsugane S (2001) Single measurement of serum phospholipid fatty acid as a biomarker of specific fatty acid intake in middle-aged Japanese men. Eur J Clin Nutr 55, 643–650.
72.Hebert JR, Ma Y, Clemow L, Ockene IS, Saperia G, Stanek EJ 3rd, Merriam PA & Ockene JK (1997) Gender differences in social desirability and social approval bias in dietary self-report. Am J Epidemiol 146, 1046–1055.
73.Katan MB, Deslypere JP, van Birgelen APJM, Penders M & Zegwaard M (1997) Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 38, 2012–2022.
74.Sun Q, Ma J, Campos H, Hankinson SE & Hu FB (2007) Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr 86, 74–81.